You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Effectiveness of tofacitinib in patients with ulcerative colitis: an updated systematic review and meta-analysis of real-world studies

Article info

Article menu

Download PDFPDF

Inflammatory bowel disease
Effectiveness of tofacitinib in patients with ulcerative colitis: an updated systematic review and meta-analysis of real-world studies

Authors

  • Chien-Hung Lin Division of Pediatric Immunology and Nephrology, Department of Pediatrics, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCollege of Science and Engineering, Fu Jen Catholic University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Wen-Sheng Liu School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCollege of Science and Engineering, Fu Jen Catholic University, Taipei, TaiwanDivision of Nephrology, Department of Medicine, Taipei City Hospital Zhongxing Branch, Taipei, TaiwanInstitute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Hsinchu, TaiwanDepartment of Special Education, University of Taipei, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Chuan Wan Department of Pediatrics, Taipei City Hospital Zhongxing Branch, Taipei, TaiwanInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Hsin-Hui Wang Division of Pediatric Immunology and Nephrology, Department of Pediatrics, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanInstitute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Hsin-Hui Wang; hhwang{at}vghtpe.gov.tw; Dr Chuan Wan; dac78{at}tpech.gov.tw
View Full Text

Citation

Lin C, Liu W, Wan C, et al
Effectiveness of tofacitinib in patients with ulcerative colitis: an updated systematic review and meta-analysis of real-world studies
BMJ Open Gastroenterology 2024;11:e001347. doi: 10.1136/bmjgast-2024-001347

Publication history

  • Received January 9, 2024
  • Accepted October 24, 2024
  • First published December 12, 2024.
Online issue publication 
December 12, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.